WBSMDA: Within and between Score for MiRNA-Disease Association prediction

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Xing ^a   Yan, Chenggang Clarence ^b,c   Zhang, Xu ^d   You, Zhu Hong ^e   Deng, Lixi ^a,f   Liu, Ying ^g   Zhang, Yongdong ^a   Dai, Qionghai ^c  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b HANGZHOU DIANZI UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

^e CHINA UNIVERSITY OF MINING AND TECHNOLOGY   (China)

^f UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^g BEIHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ALGORITHM; BIOLOGY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN; NEOPLASM; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

ALGORITHMS; COMPUTATIONAL BIOLOGY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84958291994     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21106     Document Type: Article

References (75)

1. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004).
2. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
3. Meister, G., Tuschl, T. Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349 (2004).
4. Ambros, V. microRNAs: tiny regulators with great potential. Cell 107, 823-826 (2001).
5. Jopling, C. L., Yi, M. K., Lancaster, A. M., Lemon, S. M., Sarnow, P. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA. Science 309, 1577-1581 (2005).
6. Vasudevan, S., Tong, Y., Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934 (2007).
7. Griffiths-Jones, S., Grocock, R. J., Van Dongen, S., Bateman, A., Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34, D140-D144 (2006).
8. Kozomara, A., Griffiths-Jones, S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39, D152-D157 (2011).
9. Cheng, A. M., Byrom, M. W., Shelton, J., Ford, L. P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33, 1290-1297 (2005).
10. Karp, X., Ambros, V. Encountering microRNAs in cell fate signaling. Science 310, 1288-1289 (2005).
11. Miska, E. A. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15, 563-568 (2005).
12. Xu, P., Guo, M., Hay, B. A. MicroRNAs and the regulation of cell death. Trends Genet 20, 617-624 (2004).
13. Alshalalfa, M., Alhajj, R. Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures. BMC bioinformatics 14, 51 (2013).
14. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
15. Cui, Q., Yu, Z., Purisima, E. O., Wang, E. Principles of microRNA regulation of a human cellular signaling network. Mol Syst Biol 2, 46 (2006).
16. GriffithsJones, S. miRBase: microRNA sequences and annotation. Curr Protoc Bioinformatics. 12, 1-10 (2010).
17. Esquela-Kerscher, A., Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269 (2006).
18. Latronico, M. V., Catalucci, D., Condorelli, G. Emerging role of microRNAs in cardiovascular biology. Circ Res 101, 1225-1236 (2007).
19. Lu, M. et al. An analysis of human microRNA and disease associations. PLoS One 3, e3420 (2008).
20. Yu, Z. et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res 35, 4535-4541 (2007).
21. Png, K. J. et al. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 25, 226-231 (2011).
22. Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152 (2008).
23. Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046 (2009).
24. Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 103, 2257-2261 (2006).
25. Ribas, J. et al. miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 69, 7165-7169 (2009).
26. Wang, R. et al. MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1. PLoS One. 7, e46173 (2012).
27. Wang, R. et al. MiR-185 is involved in human breast carcinogenesis by targeting Vegfa. FEBS letters 588, 4438-4447 (2014).
28. Hirota, T. et al. Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues. Lung Cancer 77, 16-23 (2012).
29. Calin, G. A., Croce, C. M. MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866 (2006).
30. Jiang, Q. et al. Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Syst Biol 4, 52 (2010).
31. Jiang, Q., Wang, G., Jin, S., Li, Y., Wang, Y. Predicting human microRNA-disease associations based on support vector machine. Int J Data Min Bioinform 8, 282-293 (2013).
32. Chen, X. Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA. Sci Rep 5, 13186 (2015).
33. Chen, X. et al. RBMMMDA: predicting multiple types of disease-microRNA associations. Sci Rep 5, 13877 (2015).
34. Chen, X. et al. Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity. Sci Rep 5, 11338 (2015).
35. Chen, X., Yan, G.-Y. Semi-supervised learning for potential human microRNA-disease associations inference. Sci Rep 4, 5501 (2014).
36. Chen, X., Yan, G.-Y. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics 29, 2617-2624 (2013).
37. Chen, X., Liu, M.-X., Yan, G.-Y. RWRMDA: predicting novel human microRNA-disease associations. Mol Biosyst 8, 2792-2798 (2012).
38. Chen, X., Liu, M. X., Cui, Q. H., Yan, G. Y. Prediction of Disease-Related Interactions between MicroRNAs and Environmental Factors Based on a Semi-Supervised Classifier. PloS One 7, e43425 (2012).
39. Chen, X. KATZLDA: KATZ measure for the lncRNA-disease association prediction. Sci Rep 5, 16840 (2015).
40. Perez-Iratxeta, C., Wjst, M., Bork, P., Andrade, M. A. G2D: a tool for mining genes associated with disease. BMC Gene 6, 45 (2005).
41. Perez-Iratxeta, C., Bork, P., Andrade, M. A. Association of genes to genetically inherited diseases using data mining. Nature Gene 31, 316-319 (2002).
42. Aerts, S. et al. Gene prioritization through genomic data fusion. Nat Biotechnol 24, 537-544 (2006).
43. Xuan, P. et al. Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors. PLoS One 8, e70204 (2013).
44. Kler, S., Bauer, S., Horn, D., Robinson, P. N. Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 82, 949 (2008).
45. Chen, X., Liu, M.-X., Yan, G.-Y. Drug-target interaction prediction by random walk on the heterogeneous network. Mol Biosyst 8, 1970-1978 (2012).
46. Chen, X., Yan, G. Y., Liao, X. P. A novel candidate disease genes prioritization method based on module partition and rank fusion. OMICS 14, 337-356 (2010).
47. Xu, J. et al. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: Case study of prostate cancer. Mol Cancer Ther 10, 1857-1866 (2011).
48. Shi, H. et al. Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes. BMC Syst Biol 7, 101 (2013).
49. Mk, S., Pletscher-Frankild, S., Caro, A. P., Gorodkin, J., Jensen, L. J. Protein-driven inference of miRNA-disease associations. Bioinformatics 30, 392-397 (2013).
50. Xu, C. et al. Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles. Mol BioSyst. 10, 2800-2809 (2014).
51. Li, Y. et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Res 42, D1070-D1074 (2014).
52. Jiang, Q. et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 37, D98-D104 (2009).
53. Yang, Z. et al. dbDEMC: a database of differentially expressed miRNAs in human cancers. BMC Genomics. 11, S5 (2010).
54. Ogata-Kawata, H. et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One 9, e92921 (2014).
55. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin. 61, 69-90 (2011).
56. Drusco, A. et al. MicroRNA profiles discriminate among colon cancer metastasis. PLoS One. 9, e96670 (2014).
57. Shi, B., Sepp-Lorenzino, L., Prisco, M., Linsley, P., Baserga, R. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem. 282, 32582-32590 (2007).
58. Guo, C. et al. The noncoding RNA, miR126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3kinase signaling and is frequently lost in colon cancers. Gene Chromosome Canc 47, 939-946 (2008).
59. Tsang, W. P., Kwok, T. T. The miR-18a microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 30, 953-959 (2009).
60. Arndt, G. M. et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC cancer 9, 374 (2009).
61. Gibcus, J. H. et al. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 11, 167-176 (2009).
62. Xie, L. et al. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood 119, 3503-3511 (2012).
63. Coiffier, B. Monoclonal antibody as therapy for malignant lymphomas. C R Biol. 329, 241-254 (2006).
64. Leich, E. et al. MicroRNA profiles of t (14; 18)-negative follicular lymphoma support a late germinal center B-cell phenotype. Blood 118, 5550-5558 (2011).
65. Uhl, E., Krimer, P., Schliekelman, P., Tompkins, S. M., Suter, S. Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of Band TCell lymphomas. Gene Chromosome Canc 50, 950-967 (2011).
66. Goto, Y., Kurozumi, A., Enokida, H., Ichikawa, T., Seki, N. Functional significance of aberrantly expressed microRNAs in prostate cancer. Int J Urol 22, 242-252 (2015).
67. Mu, P., Deng, S., Fan, X. MicroRNAs in Prostate Cancer: Small RNAs with Big Roles. J Clin Cell Immunol 6, 2 (2015).
68. Siegel, R., Naishadham, D., Jemal, A. Cancer statistics, 2013. CA Cancer J Clin. 63, 11-30 (2013).
69. Hart, M. et al. The protooncogene ERG is a target of microRNA miR145 in prostate cancer. FEBS J. 280, 2105-2116 (2013).
70. Sun, D. et al. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells. Oncogene 33, 1448-1457 (2014).
71. Porkka, K. P. et al. MicroRNA expression profiling in prostate cancer. Cancer Res 67, 6130-6135 (2007).
72. Prueitt, R. L. et al. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68, 1152-1164 (2008).
73. Fujita, Y. et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun. 377, 114-119 (2008).
74. Wang, D., Wang, J., Lu, M., Song, F., Cui, Q. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics 26, 1644-1650 (2010).
75. Shi, J.-Y., Liu, Z., Yu, H., Li, Y.-J. Predicting Drug-Target Interactions via Within-Score and Between-Score. Biomed Res Int 2015, 350983 (2015).